Literature DB >> 16307856

Antinociceptive effect from Ipomoea cairica extract.

A A Ferreira1, F A Amaral, I D G Duarte, P M Oliveira, R B Alves, D Silveira, A O Azevedo, D S Raslan, M S A Castro.   

Abstract

Ipomoea cairica L. Sweet (Convolvulaceae) is used in Brazilian folk medicine for the treatment of rheumatism and inflammations. Ipomoea cairica ethanolic extract (100, 300, 1000 and 3000 mg/kg; per os) induced dose-dependent reduction of response in the formalin test inflammatory phase in mice. The same dose range did not modify neurogenic pain in formalin test, tail-flick reflex latency, carrageenan-induced paw edema, and Rota-Rod test motor performance. From the bio-active fraction 3,5-di-O-caffeoylquinic acid and 4,5-di-O-caffeoylquinic acid were obtained. These compounds have been previously reported to have analgesic and antioxidative effects. A possible explanation for the antinociception is that somehow the compounds present in the extract reduced the release of pro-nociceptive mediators unrelated to carrageenan-induced edema, such as histamine. Interestingly, caffeoylquinic acid derivatives have been reported to inhibit histamine release on in vitro models. The isolated caffeoylquinic acids could explain, at least in part, the antinociceptive effect of Ipomoea cairica polar extract.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16307856     DOI: 10.1016/j.jep.2005.10.012

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  8 in total

1.  Anti-inflammatory and antinociceptive properties of the hydroalcoholic fractions from the leaves of Annona crassiflora Mart. in mice.

Authors:  Cristina da Costa Oliveira; Natália Alves de Matos; Clarice de Carvalho Veloso; Gisele Avelar Lage; Lúcia Pinheiro Santos Pimenta; Igor Dimitri Gama Duarte; Thiago Roberto Lima Romero; André Klein; Andrea de Castro Perez
Journal:  Inflammopharmacology       Date:  2018-01-25       Impact factor: 4.473

2.  Antibacterial activity of traditional medicinal plants used by Haudenosaunee peoples of New York State.

Authors:  Frank M Frey; Ryan Meyers
Journal:  BMC Complement Altern Med       Date:  2010-11-06       Impact factor: 3.659

3.  Antinociceptive activity of the chloroform fraction of Dioclea virgata (Rich.) Amshoff (Fabaceae) in mice.

Authors:  Vanine Gomes Mota; Fabíola Lélis de Carvalho; Liana Clébia Soares Lima de Morais; Jnanabrata Bhattacharyya; Reinaldo Nóbrega de Almeida; Jacicarlos Lima de Alencar
Journal:  J Biomed Biotechnol       Date:  2011-07-05

4.  Effects of silymarin on neuropathic pain and formalin-induced nociception in mice.

Authors:  Faezeh Vahdati Hassani; Ramin Rezaee; Hasan Sazegara; Mahmoud Hashemzaei; Kobra Shirani; Gholamreza Karimi
Journal:  Iran J Basic Med Sci       Date:  2015-07       Impact factor: 2.699

5.  Larvicidal efficacy of different plant parts of railway creeper, Ipomoea cairica Extract Against Dengue Vector Mosquitoes, Aedes albopictus (Diptera: Culicidae) and Aedes aegypti (Diptera: Culicidae).

Authors:  Rattanam AhbiRami; Wan Fatma Zuharah; Maniam Thiagaletchumi; Sreeramanan Subramaniam; Jeevandran Sundarasekar
Journal:  J Insect Sci       Date:  2014-01-01       Impact factor: 1.857

6.  Four new pentasaccharide resin glycosides from Ipomoea cairica with strong α-glucosidase inhibitory activity.

Authors:  Jie-Tao Pan; Bang-Wei Yu; Yong-Qin Yin; Jie-Hong Li; Li Wang; Li-Bing Guo; Zhi-Bin Shen
Journal:  Molecules       Date:  2015-04-14       Impact factor: 4.411

7.  Bioguided Phytochemical Study of Ipomoea cairica Extracts with Larvicidal Activity against Aedes aegypti.

Authors:  Víctor Álvarez Valverde; Gerardo Rodríguez Rodríguez; Silvia Argüello Vargas
Journal:  Molecules       Date:  2022-02-16       Impact factor: 4.411

8.  A chromosome-level reference genome of a Convolvulaceae species Ipomoea cairica.

Authors:  Fan Jiang; Sen Wang; Hengchao Wang; Anqi Wang; Dong Xu; Hangwei Liu; Boyuan Yang; Lihua Yuan; Lihong Lei; Rong Chen; Weihua Li; Wei Fan
Journal:  G3 (Bethesda)       Date:  2022-08-25       Impact factor: 3.542

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.